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Toxicity of Vesicant Agents Scheduled for
Destruction by the Chemical Stockpile
Disposal Program
by A. PR Watson1 and G. D. Griffin1
The vesicant agents of the unitary chemical munitions stockpile include various formulations of sulfur
mustard [bis-(2-chloroethyl) sulfide; agents H, HD, and HT] and small quantities of the organic arsenical
Lewisite [dichloro(2-chlorovinyl) arsine; agent LI. These agents can be dispersed in liquid, aerosol, or vapor
form andarecapable ofproducingseverechemicalburnsupondirectcontactwithtissue. Moisttissuessuchas
theeyes,respiratorytract,andaxillaryareasareparticularlyaffected.Availabledatasummarizingacutedose
response in humans and laboratory animals are summarized. Vesicant agents are also capable ofgenerating
delayed effects such as chronic bronchitis, carcinogenesis, orkeratitis/keratopathy ofthe eye under appropri-
ate conditions ofexposure and dose. These effects may not become manifest until years following exposure.
Risk analysis derived from carcinogenesis data indicates that sulfur mustard possesses a carcinogenic
potency similar to that ofbenzo[a]pyrene. Because mustard agents are alkylating compounds, they destroy
individual cells by reaction with cellular proteins, enzymes, RNA, and DNA. Once begun, tissue reaction is
irreversible. Mustard agents are mutagenic; data for cellular and laboratory animal assays are presented.
Reproductive effects have notbeen demonstrated in the offspringoflaboratory rats. Acute Lewisite exposure
has been implicated in cases ofBowen's disease, an intraepidermal squamous cell carcinoma. Lewisite is not
known to generate reproductive or teratogenic effects.
Introduction
This paper is the second in a journal series of review
articles synthesizingpertinenttoxicological data on chem-
ical wafare agents scheduled for destruction by the
Department of the Army (DoA) in the 1990s. The first
paper in this series (1) summarized recommended
treatment/decontamination protocols for the organo-
phosphate nerve agents VX [S-(diisopropylamino-
ethyl)methylphosphonothiolate, o-ethylester], GA[Tabun;
N-N-dimethylphosphoroamidocyanidate, ethylester], and
GB [Sarin;methylphosphonofluoridate, isopropylester] as
well as the vesicant (blister) agents H, HD, HT [various
forms of sulfur mustard, bis(2-chloroethyl)sulfide], and
Lewisite [an organic arsenical, dichloro (2-chlorovinyl)-
arsine]. The current paper focuses on the acute and
delayed toxicity of vesicant agents, some of which are
known carcinogens.
The Department of Defense Authorization Act of 1986
(PL 99-145) directed and authorized the Secretary of
Defense to destroy the United States' stockpile of lethal
unitary chemical munitions and agents by September 30,
1994. The Act was amended in 1988 to permit operations
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testing ofa commercial-scale incinerator design atJohns-
ton Island in the South Paciflc and to allow for unitary
munition disposal completion by April 30, 1997. (The cur-
renttargetcompletiondateis1999.) Chemicalandphysical
properties ofthese agents are detailed in Carnes (2) and
summarized in Thble 1. All but approximately 6% of the
U.S. stockpile of unitary munitions and bulk agent is
currently stored at eight separate locations in the conti-
nental U.S. as bombs, cartridges, mines, projectiles, spray
tanks, and ton containers (Fig. 1). The remainder is either
stored on Johnston Island or was transported from a
militarysitenearClausen,Germany,toJohnstonIslandin
1990. The Department of the Army's current method of
choice for agent destruction is high-temperature (1130°-
1400°C) incineration (4).
The process of "reverse assembly" and munition dis-
posal that precedes agent incineration is thoroughly
addressed in the final programmatic environmental im-
pact statement [FPEIS (3)] commissioned by the Chemi-
cal Stockpile Disposal Program (CSDP) activity of the
U.S. Army Toxic and Hazardous Materials Agency
(USATHAMA). The process is also summarized in recent
papers by Carnes (2) and Carnes and Watson (5). The
analysis containedwithin the FPEISled to the February,
1988,decisionbythen-UndersecretaryoftheArmy,James
R. Ambrose, to proceed with on-site incineration disposal
pending completion ofsite-specific analyses.WATSON AND GRIFFIN
Thble 1. Physical and chemical characteristics ofvesicant agents.
Liquid
Common Vapor pressure density at Freezing
Agent name CASno.a Chemical name Chemical formula at 250C 250C point Color
H Mustard 505-60-2 bis(2-Chloroethyl) C4H8C12S 0.08 mm Hgb 1.27 g/cm3 8-120C Amber to
sulfide dark brown
HD Mustard 505-60-2 bis(2-Chloroethyl) C4H8Cl2S 0.11 mm Hg 1.27 g/cm3 140C Clear to pale
(distilled) sulfide yellow to
black
HT Mustard 60% HD and T = C8H16Cl2OS2 0.104 mm HG 1.27 g/cm 1°C Amber to
40% TC dark brown
L Lewisite 541-25-3 Dichloro(2-chloro- C2H2AsCl3 0.58 mm Hg 1.89 g/cm3d -18oCe Amber to
vinyl)arsine dark brown to
black
aChemical Abstracts Service number.
bAt200C.
cAgent T is bis[2(2-chloroethylthio)ethyl]ester; it is CAS no. 63918-89-8.
dVaries with purity ofsample.
eVaries + 0.1°C, depending on purity and isomers present.
The evaluation of vesicant toxicity data that follows is
intended to provide background and insight to host com-
munity emergency planners and health professionals as
they prepare for the advent of the disposal program as
well as access to previously unavailable "grey literature"
formembers ofthe international-communityinterested in
vesicantcontrolanddisposal. Recentworld events, such as
thereunificationofGermanyandtheGulfWar,haveraised
concerns regarding public access to former military sites
where chemical munitions were manufactured, stored, or
armed. The current review will provide information rele-
vanttoanydecommissioningdecisionsinvolvingvesicants.
Vesicant Agent Characteristics
The active ingredient in H and HD and a major compo-
nent (60%) of HT is the same chemical compound, bis(2-
FIGURE 1. Distribution oftheunitarychemicalweaponsstockpilethroughoutthecontinental UnitedStates[smallquantities ofGAand Lewisitearealso
stored at Tooele Army Depot (3)].
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chloroethyl)sulfide (CAS no. 505-60-2; Table 1). Many
names, such as mustard gas, sulfur mustard, mustard,
yperite, etc., have been applied to this agent. Throughout
this analysis we will use the terms mustard or mustard
agent as a synonym for sulfur mustard agents. Nitrogen
mustardis adifferentchemicalagentandis notpartofthe
unitary stockpile scheduled for disposal. The term "mus-
tard gas" is amisnomer because the chemical is a liquid at
ordinary environmental temperatures. The chemical war-
fare agent H is an agent containing 70% sulfur mustard
plus 30% sulfur impurities and is manufactured by the
unstable Levinstein process. The chemical warfare agent
HD is purified sulfurmustard fromwhich impurities have
been removed by distillation and washing. Agents H and
HD will not be considered separately in the ensuing
toxicological discussion. Somephysicalpropertiesofsulfur
mustard are listed in Table 1.
Mustard has an odor like garlic. It has significant
volatility atordinary temperatures, sothatmustardvapor
would be in the air immediately surrounding droplets of
liquid mustard. Thus, the hazard ofhuman contact is not
only with droplets of liquid agent, but also with agent
vapors. Because of its low aqueous solubility, mustard
agent is very persistent in the environment.
HT is aproduct ofa reaction thatyields about 60% HD
(describedabove), <40%T(bis[2(2-chloroethylthio)ethyl]-
ether; CAS no. 63918-89-8), plus a variety of sulfur con-
taminants andimpurities. Itis very similar in appearance
and biological activity to H/HD, but it possesses greater
toxicityandstabilityduetothepresenceofT,whichlowers
the freezing point and adds toxic properties to the mix-
ture. Thus, HTisconsidered tobemore activethan H/HD.
Agent HTis also liquid at room temperature butis soluble
only in organic solvents. Its poorwater solubilitymakes it
a persistent contaminant ofsoils and surfaces other than
rubber, which it readily permeates. Hydrolysis in water
occurs only after prolonged boiling, while caustic alkalies
hydrolyze HT readily. See Table 1 for a more complete
physical description of HT.
Lewisite (Agent L) is an arsenical vesicant (dichloro[2-
chlorovinyl]arsine); CASno.541-25-3) (Table1).Thisagent
isapproximately10timesmorevolatilethanHDandcanbe
used as a "moderate irritant" vapor over great distances.
Lewisite is liquid at room temperature and is onlyslightly
soluble in water. It is considered of intermediate per-
sistency in soils because ofits low water solubility (6). It
decomposes upon application of heat and may degrade
considerably upon shell detonation; it is reasonably stable
when stored free ofwater contamination (6).
Acute Toxicity
Mustard agents aremuchlesspotentthan nerve agents
undercomparable conditions ofexposure. Thehuman skin
LD50forVX, anorganophosphate nerve agent, is 0.04mg/
kg; thecomparable doseforH/HD is100mg/kg, ora2500-
fold difference (6,7).Available hospital records fromWorld
War I and sketchycasualtyreports from the recent Iran-
Iraq conflict indicate mortality rates of 1-3% from acute
sulfur mustard exposure (8,9). Actual battlefield con-
centrations to which victims were exposed have not been
re-portedbutmaywell havebeenin excess of1500mg-min/
m, the sulfur mustard LCt50 for unprotected adult per-
sonnel (6). Exposure estimates from a World War II
Japanese poison gas factoryhave suggested thatmustard
air concentrations between 50 and 70 mg/m3 are acutely
irritating and can produce most of the acute signs of
mustard poisoning (10).
Warfare use ofvesicants decreases the opponents' abil-
ity to fight by producing chemical burns on tissues that
come into contact with either vapors or liquid droplets/
aerosols. Exposed skin surfaces, eyes, nose, throat, bron-
chial, and upper gastrointestinal tract are all at risk. The
moist surfaces ofperspiring skin, conjunctiva of the eye,
airway mucosa or mucous membranes preferentially
absorbmustard agent and distribute it over alarger area.
Thus, theunprotected eyeis consideredthemost sensitive
organtotheactionofH-agents, andambienttemperature/
humidity govern the degree of "casualty effect." Under
hot, humidconditionswhenlargeareasofskinarelikelyto
be wetwith perspiration, much lower mustard concentra-
tions generate debilitating effects (Table 2).
After initial tissue damage, various debilitating effects
follow, such as the development of large, painful blisters
that arise on exposed skin. An individual exposed to blister-
ingconcentrations ofagentisincapacitated, oftenforweeks,
before returning to normal activity. A description of acute
clinical signs produced by individual vesicants follows.
Agents H/HD
Mode ofAction. In terms ofchemical reactivity, sulfur
mustard is a classic alkylating agent and readily reacts
with components of DNA, RNA, and proteins (19,25-28).
The chemical modifications that various biological mole-
cules undergo through alkylation can result in severe
disorganization of their normal biological function. Mus-
tardisconsidered acellpoison(29)andisparticularlytoxic
to mitotic cells. Cytostasis, mutation, and slow cell death
can also result (30). It was known from early biological
studies of mustard that this agent produced many
cytological abnormalities (31). Because ofthe similarity of
cellular lesions produced by mustard and X-rays, the
mustards and other simnilarly acting chemicals are some-
times termed "radiomimetic," that is, imitating the effect
of radiation (32,33). Thus, intestinal epithelial damage
leading to diarrhea, depression of proliferation of white
cell precursors in the bone marrow leading to depressed
white blood cell counts, and injury to respiratory epi-
thelium can all be features ofmustard poisoning, as they
are of radiation injury (30). The skin epithelium is an
important target because of its proliferating basal cell
layer (30). It should not be concluded, however, that mus-
tard is only effective against proliferating cells; at suffici-
ent concentration, it produces cellular necrosis in any
exposed cells (26,30).
From abiochemical point ofview, itwould be important
to knowthe exactmolecular sites thatmustard attacks, as
this knowledge might allow development ofrational ther-
apy at the molecular level. Unfortunately, the problem
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Exposure route
Inhalation LCt50, mg-minimn
Human (estimated)
Monkey
Goat
Dog
Cat
Rabbit
Guinea pig
Rat
Mouse
Table 2. Acute toxic effects ofvesicant agents H/HD, HT, Lewisite, and T.
H/HD HT Lewisite T
1,500a
800
1,900
600
700
1,025
1,700
800-1,512
b
860-1,38v
1,200-1,500
100-200
3,000-6,000
3,000-6,000
1,100 (10 days)
820 (15 days)
1,500 (9 min)
150 (10 min)
References
.'400 U.S. DoA (6); Robinson (11)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6); Robinson (11)
U.S. DoA (6); Robinson (11)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6,12)
U.S. DoA (6,12)
U.S. DoA (6)
Inhalation LCt50, mg-min/m3 (head exposed, body protected)
Mouse
Percutaneous LCt5o (vapor), mg-min/m3 (head protected, body exposed)
Human (estimated) 10,000
Monkey 13,000
Dog 7,700
Cat
Rabbit
Guinea pig
8,700
5,000
-20,000
Rat
Mouse
-3,000
3,400
Percutaneous LD50 (liquid), mg/kg body weight (head protected, body exposed)
Mouse
Rat
Rabbit
Guinea pig
Dog
Goat
1,400-1,600 (10 min)
100,000
40,000 (10 min)
30,000 (30-60 min)
30,000 (30-45 min)
15,000 (10 min)
20,000-25,000
(10-40 min)
20,000 (9-25 min)
300-7,000 (10 min)
15
15-24
5-6
12
'70,38
10-24
Percutaneous + inhalation LCt5O, mg-min/m3 (no protection)
Mouse
Rat
Guinea pig
Rabbit
Goat
Dog
Skin LD50 mg/kg body weight (applied as liquid)
Human (estimated) 100
Farm animals (unspecified)
Dog
Rabbit 100
Guinea pig
Rat 9,18
15 (96-hr mortality)
194 (24-hr mortality)
92 Mouse
Goat
900-2800 (10 min)
500 (9-14 min)
1,500 (9-25 min)
580 (60-180 min)
20,000
1,000 (9-14 min)
470 (60-180 min)
1,200 (7.5-13 min)
1,500 (60-310 min)
1,250 (100-255 min)
1,400 (7.5-15 min)
10,15
15,38
4,6
12
15-24
15
15
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (12)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
NDRC (13); U.S. DoA (12)
Cameron et al. (14), U.S. DoA
(12)
U.S. DoA(6), Danielli et al. (15),
Cameron et al. (14)
NDRC (13)
Young (16), U.S. DoA (6,12),
Cameron et al. (14)
Vojvodic et al. (17)
Vojvodic et al. (17)
U.S. DoA (6), NDRC (13)
Cameron et al. (14)
Intravenous LD50, mg/kg body weight
Dog 0.2
Rabbit -1.1-4.5
Rat 0.7-3.3
Mouse 3.3, 8.6
Oral LD50, mg/kg body weight
Rat
2.0
0.5, 2.0
50 17
U.S. DoA (6); NRDC (13)
U.S. DoA(6); Cameron etal. (14)
Anslow et al. (18)
Anslow et al. (18)
U.S. DoA (6,12)
continued
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
U.S. DoA (6)
262TOXICITY OF VESICANTAGENTS
Table 2. Continued.
Exposure route H/HD HT Lewisite T References
Incapacitating dose, ICt50, mg-min/m3
Human, percutaneous 2,000 (70-80oF)c None established >1,500 U.S.DoA(6);McNamaraetal. (19)
(masked) -1,000 (900F)
Human, eyes 200 None established <300 U.S. DoA (6)
Minimum effective dose, ED
Human skin (irritation) 95 p.g/man NRDC (13)
Human skin (blisters) 50 mg-min/m3d 3.5 mg/man -200 mg-min/m3 4 mg/ U.S. DoA (6); Robinson (11)
4 mg/man (30 min) man
Human eyes (marginal) 12-70 mg-min/m3 U.S. DoA (6)
Conjunctivitis 30 mg-min/m3 Dahl et al. (20)
(60 min)
Reddening, no 70 mg-min/m3 U.S. DoA (6)
incapacitation
Reddening, mild 90 mg-min/m3 U.S. DoA (6)
incapacitation
Rabbit skin -25 mg-min/m3 U.S. DoA (6)
(30 min)
Rabbit eyes Similar to HD 1 mg-min/m: U.S. DoA (6)
(30 min)
Dog skin -50mg-min/m 3 U.S. DoA (6)
(30 min)
Dog eyes -20mg-min/m3 U.S. DoA (6)
(30 min)
No effect dose, mg/min/m3
Human eyes <12 McNamara et al. (19)
Human (estimated) 2(. 900F) McNamara et al. (19)
Severe systemic effects, mg/kg body weight
Human skin (estimated) 13.4 Windholz et al. (21)
8.1 Sollman (22)
Inhalation, lowest lethal dose, mg/mi3
Human 150 (10 min) 48 (30 min) Back et al. (23)
70 (30 min) Inada et al. (10)
Skin absorption, lethal, mg/kg body weight
Human 64 37.6 WHO (24); Sollman (22)
53.7 Windholz et al. (21)
aBecause HD exposures are cumulative, the lethal dose is not changed with variations in time ofexposure, within reasonable limits.
bRanges ofLCt5o values are summarized for all exposure times reported.
cIncapacitating dose varies significantly with amount of perspiration on skin surface, which is in turn dependent on ambient temperature and
humidity levels.
dMild to moderate erythema is produced at ambient temperature of90°F.
becomes very complex because such a wide variety of
cellular targets are available for reaction with mustard.
For instance, cross-linking damage to DNA can account
for many of the deleterious cellular effects (26,32,33).
Othercellularmacromolecules arealsosusceptibleto mus-
tard attack. Levy (34) found evidence of cell membrane
modification by doses of mustard too small to effectively
alter DNA. Certain enzymes, notably hexokinase, were
inhibited when incubated in vitro with very low doses of
mustard, although themajorityofenzymes sotestedwere
not affected (25). Aninterestingbiochemicalhypothesis to
accountforthegeneration ofmustard-induced skinlesions
has been proposed by workers at the U.S. Army Medical
Research Institute of Chemical Defense (27,32). This
hypothesis links initial chemical binding of mustard to
DNA through a complex series of steps to release intra-
cellular enzymes that are responsible for the skin damage
and blistering produced by the agent.
Briefly, the sequence of steps envisioned is that the
initial DNA damage produced by mustard results in
activation ofa repair enzyme that uses NAD+ as a cofac-
tor. If the damage to DNA is extensive enough, the
enzyme's activity could result in depletion of cellular
NAD+,thusinhibitingglycolysis.Thisinturncouldresult
in stimulation ofthe hexose monophosphate shunt, which
has been found to be associated with enhanced synthesis
and release of proteases. These proteases are hypoth-
esized to be the immediate cause of the skin damage
associated with mustard exposure. It should be
emphasized that this complex sequence is a theoretical
construct: certain segments of it have been verified by
experimentation, but whether it serves to explain what
happens in mustard-damaged skin is unknown.
BecauseHcontainslessactiveingredientsthanHD (see
Table 1), it is expected to have a slightly less blistering
effect than HD (35) but to otherwise have the same
biological properties. Acute effects (8,29,36) after expos-
uretotoxicologicallyactiveconcentrations (50to >100mg-
minim3) ofmustard canbe characterized bythefollowing:
a) alatencyperiod ofseveral hours before chemical burns
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becomemanifest(athighconcentrations,immediateirrita-
tion may be produced). Because agent contact does not
produce immediate symptoms, exposed individuals often
do not promptly decontaminate or request medical
assistance; b) inflamed and painful eyes, swvollen eyelids,
and temporary blindness. The eye is affected at lower
vapor concentrations than any other tissue; c) avariety of
dose-dependent effects on the respiratory tract, including
throat discomfort, continuous hoarse coughing, nasal dis-
charges, copious mucus production, and bronchial inflam-
mation. Secondaryinfection and potentiallyfatalbroncho-
pneumoniacanresult; d)generalirritationoftheskin,first
manifested as an itching rash, which then develops (at
higher exposures) into large, painful blisters that may
require weeks to heal; e) at high doses, mustard can
depress immune system reponse and render the exposed
individual more susceptible to infections; and f) acute
lethality of1-3%.
Table 2 summarizes availableinformation regardingthe
acute toxic signs generated by certain doses of HD. The
various lethaldoses listedforhumans are estimatesbased
upon extrapolations from other species. As previously
described, evenunderwartime exposure conditions, HD is
not anotablylethal agent. Significant human exposures to
HD during operations ofthe Chemical Stockpile Disposal
Program are conceivable during a major, unplanned
release, such as a plane crash into a storage bunker (37).
These events are not very probable and have been calcu-
lated to occur with a probability approximating 1 x 10-4
or less over the life ofthe disposal program for the entire
stockpile (37). Exposures expected under such circum-
stances could occur by inhalation of HD vapors or skin
contact with vapors or liquid. Any form of percutaneous
dose summarized in Table 2 is probably not comparable to
expected exposures during normal stockpile disposal
operations. Dermal exposure to liquid HD droplets (eg.,
seeskin LD50values) forthegeneralpublicisalsounlikely
since alow-probabilityexplosivereleasewouldberequired
to generate skin doses to off-site populations (5).
Intravenous LD50 values indicate that among-species
variation spans an approximate 40-fold range. Forrabbits
and rats, intravenous LD50 values range between 1 and 4
mg/kg bodyweight. Mice seem somewhat more resistant
than rabbits and rats, while dogs are more sensitive.
From inspection of Table 2, it can be noted that the
inhalationLCt50dose approximates 1000-1500mg-min/m3
and is similar for a number ofanimal species. The human
LCt50 estimate is extrapolated from animal toxicity data.
Becausetheeffects ofHD arecumulative (i.e.,verylimited
detoxification), thelethaldoseis notsignificantlychanged,
within reasonable limits, with variations in exposure time
(6). Whatthese "reasonable" limits are (minutes orhours)
was not stated. McNamara and his colleagues (19) note
thatthe effect ofthe same HD dose isreducedwhen given
over a longer period of time; this finding suggests that
some degree of biological detoxification takes place. The
lowest reported lethal doses for H/HD in humans are 150
mg/mi3 for 10 min (23) and 70 mg/m3 for30 min (10) (Table
2).
TwotypesoflethaldermalexposurestoHD aredenoted
inTable2. In thefirst, experimental animalswere exposed
in a special chamberinwhich onlythebodywas in contact
with HD vapor or liquid, while the head remained outside
the chamber (i.e., no inhalation exposure). It seems
possible that, because of inherently low HD volatility,
condensation might occur in the vapor exposure experi-
ments. At least some of the total dose may have been
received as a liquid (droplet) application upon skin. In the
secondtypeofdermal exposuretested, datafordirectskin
application (with no protection from inhalation exposure)
ofliquid agent are presented. In all species forwhich data
are available for this comparison, the LD50 dose (on a
milligramperkilogrambasis) fordirectskin applicationof
liquid agent is an approximate order ofmagnitude larger
than that for intravenous injection. This result would be
expected because HD would reactwith the outerlayers of
skin cells, leaving only a fraction ofthe total applied dose
to reach capillaries and be absorbed systemically.
Clinical signs (8,29,33,36) associatedwith nonlethal HD
poisoning are described below. Thefollowingobservations
are not definitive with regard to timing ofmanifestations,
etc., and should be considered representative of the con-
stellation ofeffectsthatcanarise.Thebiologicalactivityof
mustard agentis characterized byalatentperiodfollowed
by severe inflammation, blistering, and local necrosis (cell
death). Medema(29) statesthatthereis anobservedeffect
within 1hrofexposure onlywhengross contactwithliquid
agent occurs.
Toxicological effects are local at the point of agent
contact with skin, eyes, or respiratory tract. The first
effect to manifest itselfis usually eye irritation (watering,
reddening, pain, swelling ofthe eyelids, etc.), taking place
2-3 hr following exposure. In the period 4-16 hr after
exposure, eyeeffectsbecome more severe, nasal discharge
occurs, nausea and vomiting may begin and recur for
several hours, and diarrhea may develop. Skin rashes also
begin to manifest themselves at this time. Twenty-four
hours after exposure, eyes can be swollen almost shut and
verypainful,exposed skinisswollenandreddened,thereis
hoarse coughing, and the throatmaybe raw andirritated.
During the next 24 hr, skin erythema may progress into
(sometimes large) blisters, and eye irritation begins to
subside (although inflammation persists for several days).
In cases of severe exposure, damage to the respiratory
tract becomes evident at this time; expectoration is copi-
ous, with mucus and occasional sloughing of tracheal
mucosa. Secondary infection of the respiratory tract can
occur (e.g., bronchopneumonia), with attendant fever. In
less severe exposures, involvement ofthe respiratorytract
may be manifested by any or all ofthe following: rhinitis,
laryngitis, tracheitis, and bronchitis. From the experience
ofWorldWarI soldiersexposedtomustard,damagetothe
throat and other portions of the upper respiratory tract
presented the greatest potential for lethal consequences
due to the development of secondary infection in the
absence of antibiotic therapy (36,38). Recovery of indi-
viduals with respiratory damage to a state where moder-
ate activitywaspossiblecould takefrom 4 to 8weeks (38).
The severity of skin lesions experienced by exposed
individuals is influenced by a number of factors indepen-
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dent of the exposure concentration, including individual
differences in skin sensitivity, ambient temperature,
amount of sweat on the skin, etc. (6,36). With milder
exposures or as the first stage of a severe exposure, skin
damagetakes theformofanitchingerythema. Withmore
severe exposures, erythematous areas begin to fill with
fluid, and ablisterarises (sometimeswith adiameter of3-
4 in), reaching a maximum size in approximately 24 hr.
After several days, theblisters usuallybreak. Blisters are
relatively painless for several days, but after 5-6 days the
pain becomes severe upon exposure to air or on contact;
sensitivity ofthe blistered area can persist for 2-3 weeks.
Ulceration ofthe blister may or may not develop; in most
severeburns, ablisterdoes notdevelop, buttheinitialburn
progresses to an ulcer, which maytake 5-7weeks to heal.
As might be expected, mustard agent burns are suscep-
tible to infection, and boils can develop in and around the
affected area,althoughthefluidfromtheblisteritselfdoes
not cause a secondary blister to develop. Any preexisting
skin damage such as cuts, abrasions or sunburn would
likely enhance the effect ofmustard at the wound site.
Table 2 presents mustard dosages that can produce the
described symptoms. Concentrations of mustard barely
perceptible by odor can produce eye damage while not
affectingthe skin ortherespiratorytract (6). Dahland his
colleagues (20) note thatvapor concentrations of0.5 pLg/L
(e.g., 0.5 mg/m3) for exposure periods of1 hr (i.e., 30 mg-
min/m3) are sufficient to produce conjunctivitis in man.
Mustard agent also rapidly penetrates the cornea; 10 min
is cited in Dahl et al. (20) and Geeraets et al. (39). Because
of this rapid penetration and subsequent disappearance
fromthecorneal surface, attemptstoirrigatetheeyemust
take place promptly after exposure. Compounding this
difficultyis the factthatthere is alatentperiod before eye
effects begin to appear (20). Mild exposures (20-70 mg/
min/m3) to HD vapor may produce lacrimation and swell-
ing, whereas more severe exposures (100 mg-min/m3) can
produce blepharospasm, blurring ofvision, edema of the
conjunctiva and eyelids, iritis, and a mucous discharge
(20,36,39). Pain is usually associated with these ocular
effects. Followingthis acutephase, there occurs agradual
regeneration of damaged tissues, so that the eyes may
become normal within weeks after exposure (20). After
severe injury, however, heavy cornealvascularization may
occur, andcorneal erosionandulcerationmaydevelop over
several months (39). A later phase is mustard-induced
keratitis orkeratopathy,whichmayoccur8-40years after
exposure andresultinvisionloss (20,26). Thispointwillbe
further discussed as a delayed effect. The no-effect dose
for the eyes of 12 mg-min/m3 (Table 2) seems reasonably
consistent with other toxicological information presented
in Table 2. The incapacitating eye dose (200 mg-min/m3)
(Table 2) is probably somewhat subjective, depending on
the individual.
Vapor, mist, and/or liquid droplets ofmustard can pro-
duce skindamage aswell as eyedamage. Basal cells ofthe
epidermis arerapidlykilledbytheagent.Separationofthe
epidermis from the underlying dermis follows, and the
resulting vascular permeability produces edema. Some
degree ofinflammatory response also occurs (27,30). Vas-
cular leakage accounts for the large blisters produced by
mustard poisoning. Doses ofHD thatcanproducevarious
degrees ofhuman skin damage reported by Papirmeister
et al. (27) are a) 0.1-1.0 [Lg/cm2 for erythema/edema, b) 1-
2.5 pLg/cm2 for edema,vesication, and c) > 2.5 pLg/cm2 for
central necrosis andvesication onthe circumference ofthe
necrotic area. Nagy et al. (40) estimate that 6 ,ug/cm2 of
mustardagentproducesvesicationin50%ofexposedsites.
Thus, small amounts of liquid mustard applied to human
skin can produce damage.
In their studies of mustard agent effects on skin of
humanvolunteers, Nagyetal. (40)reportedthattherewas
an approximate linearrelationship between the amount of
mustard that penetrated the skin and the time of
exposure, atleastovertherangeof0-30min.Theapproxi-
mate rate of penetration of mustard into human skin at
21°-23°C was 1.5 ,ug/cm2 skin area/min. No difference in
therateofmustardpenetrationbetweenthe skinofwhites
and blacks was observed (40). Nagy et al. (40) also com-
pared the skin penetration of mustard at two ambient
temperatures (22°C and 31°C); penetration was greater
(amount ofmustard penetrating at higher temperature is
approximately 1.6 times that penetrating at the lower
temperature) at 31°C, but no temperature-dependent dif-
ference in the ability ofmustard to generate blisters was
observed. As previously noted, the amount ofmoisture on
the skin surface also has a decided effect upon the degree
of damage produced by HD (6,40).
The minimal effective dose (50 mg/minim3) for human
skin exposure (Table 2) refers to development ofa mild to
moderate erythema. The time to erythema appearance
varies with exposure concentration and time as well as
skin moisture; in general, mild skin damage appears
relatively late after exposure and heals earlier than the
more extensive damage from blistering concentrations
(36). After healing, areas of skin affected by mustard
usually undergo hyperpigmentation, may become hyper-
sensitive to mechanical irritation, and can become perma-
nently scarred (36). Large individual differences
regarding skin damage susceptibilityexist; there canbe a
100-folddifferenceinskinreactionbetweenaresistantand
sensitive person (36). Note that the groin region (often
moist) is considered 10 times more sensitive to mustard
thanotherbodyregions (29). Thelevel ofskindamagethat
becomes incapacitating is, as with the eyes, somewhat
objective; the incapacitating skin dose noted in Table 2 is
1000-2000 mg-minim3 for an individual protected by a
respirator.
Blewett's article (8)includes atable (reproduced here as
Table 3) presentingthe distribution ofagent-induced inju-
ries amongbody parts ofWorld War I soldiers exposed to
battlefield concentrations of sulfur mustard. Note that
each ofthe 6980 casualties observed had an average of3.5
separate mustard injuries. Data indicate that the regions
affectedinthehighestpercentage ofvictimsweretheeyes
(86%), respiratory tract (75%), scrotum (42%), face (27%),
and anus (24%). Thus, the most vulnerable areas to the
vesicant action ofsulfur mustard are moist body parts in
general.
Acute systemic reactions to mustard are likely to occur
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Table 3. Distribution ofmustard gas injuries on bodies
ofWorld War I casualties.a
Body part Reported injuries, %
Eyes 86.1
Respiratory tract 75.3
Scrotum 42.1
Face 26.6
Anus 23.9
Back 12.9
Armpits 12.5
Neck 12.0
Arms 11.7
Chest 11.5
Legs 11.4
Buttocks 9.8
Abdomen 6.4
Thighs 6.0
Hands 4.3
Feet 1.5
aPercentage of mustard gas injuries to various body parts in 6980
World War I casualties (8,41).
with severeexposures (i.e., 2 1000mg-min/m3 (6). Some of
the toxic signs may include loss of appetite, malaise,
nausea, vomiting, depression, and fever (6,33,35) and may
appear before or concurrently with skin manifestations.
Recovery from vomiting may occur within 24-36 hr,
although the othermanifestations maycontinue forlonger
periods (6). These and collateral reactions, such as
anorexia, leukopenia, thrombocytopenia, epigastric pain,
and anemia were noted in Iranian soldiers exposed to
battlefield concentrations of sulfur mustard during the
Iran-Iraq conflict (42). Two-year follow-up of severely
exposed Iranian soldiers reported central nervous system
involvement (43).
Victims of the Bari incident ofWorld War II (in which
naval personnel swam through a floating mixture ofmus-
tardagentandfuel oilintheAdriaticSeatoescapesinking
ships) experienced a systemic, shocklike syndrome that
was notamenable to usualmedical therapy(55). In British
and French warfare agent factories during World War I
(1916-1918), aform ofsystemic poisoningwas also notedin
mustard workers who exhibited symptoms oflistlessness,
depression, headaches, indigestion, eyelid spasms, and
breathlessness (38). The concentration of mustard to
whichthesefactoryworkerswereexposedwasunreported
but was sufficiently high to cause worker deaths in some
shell-filling plants.
From a military standpoint, one of mustard's most
usefulproperties isitspersistence (6,8,29). Droplets ofthe
agent released, for example, in an explosive accident could
deposit on numerous surfaces and slowly evaporate, thus
posing a risk from agent inhalation as well as a dermal
contact hazard. Indeed, this very set of conditions was
observed in World War I after mustard shelling (8). One
reason for sulfur mustard's persistence is its characteris-
tic freezing at moderate temperatures (13°-15° C) (6);
droplets or bulk quantities would thus be expected to
remain where initially deposited during cool weather or
under winter/arctic conditions. In addition, mustard
agents do not readily dissolve in aqueous solution (water
solubility of0.68-0.92 g/L at25°C forH/HD; HTis consid-
ered insoluble) (6). Thus, bulk quantities ofmustard agent
spilled or splashed onto soilwould notdegradein amatter
ofdays (Table 4).
Reports exist ofburns to military personnel who came
incontactwithsoilcontaminatedbyHD3yearspreviously
aswell as decades-longpersistence ofHD in militaryland
dumps (46). In all cases of such lengthy persistence, the
sourcewas spilled orleakedmustard inbulk quantities: a)
An incident at Edgewood Arsenal (now the Edgewood
Area ofAberdeen ProvingGround), probably around 1921,
reported by Walker et al. (47) "men digging in an area
where there had been no new mustard for at least three
years ... were definitely burned. The mustard contami-
nated the soil due to leakage, but the total amount in the
soil was not known. It was probably very great." b) Ep-
stein et al. (48) cite a source that reported that mustard
dumped at Edgewood Arsenal in 1941 was still detectable
in 1971. The areainvolvedwas known to havebeen used as
a dump for munitions for several years. c) One positive
detection ofHD in surface soilwas reported from a closed
training area at Fort McClellan in January1973 (49). This
occurred several months after last known agent presence
in the area, which had been used for storage. Spills of
agent had been previously reported. d) During the recent
Iran-Iraq conflict, samples of air from within bomb cra-
ters 14-15 days after enemyattack contained "detectable"
to 2.5 mg/m mustard vapor concentrations, even though
the craters had undergone decontamination and excess
water was present (9).
Persistence of mustard sprayed on snow has been
reported to range from 14 to 56 days, with little migration
from the contaminated surface into the snowpack (50).
Simulated snowfall (5 cm new snow) after initial HD
deposition increased persistence, probably by means of
reduced volatilization and dissolution (51). Observation of
sulfurmustard spraydegradation onvarioussoiltypes (50
g/m2 on "sand, cultivatable soil, uncultivatable soil and
gravelly soil") under ambient conditions demonstrated
that sand exhibited the longest persistence (68 hr) and
gravelly soil the least persistence (27 hr) (45). It is thus
quitepossibleforheavilycontaminated sitestobe asource
of damaging acute exposure for days or weeks after
release, depending on the magnitude of the original con-
tamination and environmental conditions.
Agents HT/T
Agent HTis aproductofonemanufacturingprocessfor
making mustard. HT contains about 60% HD, < 40%
Table 4. Persistence times (v, hours) predicted for HD droplets on
soil under various weather conditions (45,46).a
Temperature Calm dry, Windy, dry, Light rain, Heavy rain,
°C hrUc hr hrd hrd
0 1530 1743 2215 1122
25 41.5 47.3 51.2 30.5
aTime required for agent to degrade to 0.033 mg/M2 (i.e.,. 1500-fold
degradation from initial concentration of 50 g/m2).
Calm indicates wind speed <3 m/sec.
cDryindicates rainfall intensity <0.05mm/hr (0.047 in/day).
dLight rain indicates an intensity between 0.05mm/hr and 0.3mm/hr
(0.28 in/day).
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agent T, and avariety ofsulfur contaminants and impuri-
ties. The acute effects of HD have been described above.
Agent T (bis[2(2-chloroethythio)ethyl]ether; see Table 1)
lowers the freezing point and thereby increases stability.
It also possesses significant toxic properties ofits own.
Agent T has been considered a mustard with relatively
weak vesicant action because of an observed delay in
symptom onset (52). However, the estimated human lethal
dose for inhalation (LCt50 of 40 mg-min/m3) from
exposure-to T is much less than that for agent HD (LCt50
of1500 mg-minIm3) (11) (Table 2). Thus, agent T, far from
being a mere additive, contributes considerable biological
activity to the HT mixture.
Available data characterizing HT toxicity have been
confined to studiesperformedbythe U.S.Army,which are
summarized in chemical agent data sheets (6). Results of
animal and human acute toxicity testing are presented in
Table 2. Most biological effects observed after animal
exposure to HT are similar to those induced by HD,
although induction following HT exposure is more rapid
and/or severe. This greater activity is a result of the
presence ofstable agentTinthemixture; themorevolatile
HD dissipates and leaves a reactive blend containing a
higher concentration ofT.
Agent L (Lewisite)
Lewisite [dichloro(2-chlorovinyl) arsine] is considered
not only a lethal vesicant but also a systemic poison when
absorbed intothebloodstream. Theliver, gallbladder, and
bile duct are particularly vulnerable, although damage to
the kidneys and urinary tract is also possible at high skin
doses(14).Experimental subcutaneousexposureinrabbits
targets the liver, lung, and kidneys (53). Lewisite inhala-
tion and ingestion severely damage the mucous mem-
branes ofthe airways, mouth, stomach, and intestine (14).
Likethemustard agents, Lewisiteis also acellularpoison,
but in a somewhat different manner. Rather.than indis-
criminantly destroying proteins, Lewisite directly affects
cellular enzyme systems.
Lethal exposures in humans and experimental animals
can occur via inhalation, skin or eye contact, or ingestion
(Table 2). Mustard and Lewisite exhibit approximately
equalinhalationtoxicity(1200-1500mg-min/m'); however,
Lewisite is faster acting and more toxic via direct skin
contact. According to some estimates, a2-mL skin dose of
liquid Lewisite to an adult (i.e., 37.6 mg/kg) can be fatal
(21,22). Without treatment, death from such a dose can
occur in a matter ofhours. One hypothesis contends that
immediate death is due to "Lewisite shock," or loss of
bloodplasmaresultingfromtheincreasedpermeabilityof
capillaries damaged by circulating Lewisite (14). Severely
burned victims of house fires, vehicular accidents, etc.,
suffersimilarlossofbloodplasma("burnshock"). Smaller,
but still lethal, doses ofLewisite reduce liver function and
result in death among experimental animal populations
after some delay, butusuallywithin aweekafterexposure
(14). The threshold for onset of severe systemic effects in
humansisapproximately10mg/kgtothe skin(rangeof9.1
to 13.4 mg/kg) (21,22).
Lewisite exposure is further characterized by immedi-
ate onset of pain, in direct contrast to the delayed pain
reaction of mustard agents (54,55). So it is likely that,
unless unconscious, anyone exposedto agent Lwould seek
and receive some degree ofdecontamination and/or treat-
ment. Decontamination by copious flushing with water or
mildsolutions ofsodiumbicarbonateordetergentneedsto
be particularly swift in the case of ocular exposure, in
which permanent blindness from corneal necrosis and
secondary scarring may result if decontamination is not
accomplishedwithin60 sec(6). Inflammationoftheiriscan
also result from sublethal exposures to the eye.
It is not known if Lewisite is persistent. However,
arsenicis an elemental poison and anyresidualhydrolysis,
combustion, ordecontaminationproductislikelytocontain
an arsenical compound.
Delayed Toxicity
In addition to acute effects, there is also the possibility
ofdelayedorlatenteffects arisingsometimeaftervesicant
agent exposure. For the sake of discussion and data
organization, we will use the term "delayed toxicity" or
"delayed effects" generically to encompass any adverse
biological effects that are not acute. The reader should
understand that such categorization includes effects that
might be manifested after a period ofseeming inactivity,
or that arise following long-term exposures to low con-
centrations of a given vesicant agent (i.e., chronic ex-
posure).
Agents H/HD
Becauseoftheabilitytoreactirreversiblywith avariety
of biological molecules, the resultant biological damage
couldhaveimmediateconsequences ormanifestitselfafter
aconsiderableinterval. Delayedeffects fromHD exposure
include keratitis or keratopathy of the eye; respiratory
diseases other than respiratory cancer; carcinogenesis;
mutagenesis, particularly in relation to reproductive
effects; and a generic category that includes other, less
well-defined effects. Before more detailed discussions of
these points, a brief summary of major findings is pre-
sented.
a) Among the population who sustained eye damage
from mustard exposure in World War I, some lesions that
had apparentlyhealedrelapseddecadeslaterandresulted
in eventual vision loss. b) Individuals poisoned by sulfur
mustard in World War I were at an increased risk of
developing chronic bronchitis. c) Epidemiological studies
established a direct relationship between cancer of the
respiratory tract and occupational mustard agent
exposures. d) Evidence exists that these same groups of
occupationally exposed workers (in wartime poison-gas
factories) are also at increased risk of developing skin
cancer. e) In addition, individuals whose skin has been
blistered by mustard are vulnerable to subsequent
mechanical injury at the same skin sites. ) Mustard can
induce cancer in experimental animals and mutations in a
variety of biological test systems. g) Some biological
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assays have also demonstrated heritable genetic effects,
implying that mustard produces damages in parental
germ cells. h) Evidence for human reproductive effects
following mustard exposure is equivocal.
Tbxicity to the Eye. Eye damage suffered by most
soldiers exposed to mustard in World War I was tempo-
raryinnature, and nopermanenteffectswere observed at
the time (26). In a smaller number of soldiers, where the
eye was probably exposed to higher vapor concentrations
or liquid droplets, a permanent, relapsing keratitis
(delayed keratopathy) developed (26,39). This chronic con-
ditionischaracterized byrecurringerosion andulceration
of the cornea, eventual vision impairment and, in some
cases, blindness (26,39). The latent period forthis delayed
effect hasbeen observed to range from 8 to 40years after
apparent recovery from the initial acute injury (20). In
some cases the condition has been observed to relapse for
decades (26).
One case involving a single acute injury to an adult
victim who received immediate medical attention after
direct exposure to sulfur mustard (unreported whether
vapor or liquid droplets) illustrates the potential for
delayed toxicity to the eye (39). In spite of copious eye
irrigation with physiologic saline within a few minutes
after exposure, as well as antibiotic and atropine sulfate
therapy, corneal damage was apparent and did not com-
pletely resolve with time. Two years after the event, the
cornea was reported to be opaque, and the victim's vision
was reduced to light perception only. Therapeutic corneal
transplantation was recommended. This maybe an excep-
tional case, as the dose to the eye could have been very
large, or the individual could have been hypersensitive or
experienced an infection or additional, unrelated injury.
Balanced against this must be the experience of exposed
World War I soldiers, many ofwhom experienced severe
acute eye effects but did not develop any permanent
damage (26).
Nonmalignant Respiratory and Skin Damage. Evi-
dence from occupational andwartime exposures indicates
that, under appropriate conditions, mustard agent can
induce long-term respiratory damage. Reported ailments
range from asthmalike conditions to a severe chronic
emphysematous bronchitis, and secondaryinfections such
as bronchopneumonia and tuberculosis (33,36). Among
groupsofWorldWarI soldiersexposedtomustard,results
ofsubsequent epidemiological studies can be summarized
as follows.
InastudyofBritishWorldWarIpensioners,thehistory
ofrespiratory disease in warveterans previously exposed
to battlefield concentrations of mustard agent was com-
pared to that of pensioners with chronic bronchitis and
amputees (56). Neither the chronic bronchitis nor the
amputee group had experienced a mustard exposure.
When compared with the amputee group and the general
male population, significant excess mortality from chronic
bronchitis, tuberculosis, and pneumoniawas noted in both
the group exposed to mustard and the group exhibiting
chronic bronchitis. The difference in mortality was most
notable in pensioners less than 50 years ofage (56).
Aninvestigation ofU.S.WorldWarIveteranscompared
former soldiers who underwent mustard exposure during
the war with nongassed veterans who had a diagnosed
pneumoniainfection duringthe influenza outbreak of1918
andveteranswhohadbeenwoundedintheextremities,but
who had not been a victim of pneumonia or mustard
exposure (57). The mustard group exhibited significantly
greater mortality from tuberculosis and pneumonia than
eitherreference group. Duringthe entire follow-upperiod
(1919-1955), mortality from respiratory diseases (exclu-
sive oftuberculosis and neoplasms) was 3.5, 2.7, and 1.9%
for the mustard agent, pneumonia, and control cohort,
respectively. The mortalityfrom respiratory diseaseswas
elevated in the mustard agent group. (The statistical sig-
nificance ofthis elevation is unclear in the report. Beebe
(57) states that the comparison between the mustard
agent and wounded control rosters is "well outside the
expectedrange ofchance.") Itwasalsofoundthatofthose
in the mustard cohort dying ofrespiratory disease, there
was a significant (p < 0.01) excess of pneumonia deaths
(2.9%)whencomparedtothewoundedgroup(1.4%).When
respiratorytuberculosiswasexaminedasacauseofdeath,
mortality in the mustard gas group (3.6%) was signifi-
cantly (p < 0.01) elevated compared to the pneumonia
(2.9%) andwounded (2.1%) cohorts. Inthefollow-upperiod
(1929-1938), the rate of respiratory death was highest in
the mustard group (1.63 per 1000 men per year) when
compared to rates of0.70 and 0.54 for the pneumonia and
control groups, respectively.
Weapons plant workers exposed to toxic vesicant con-
centrations under wartime conditions have been the sub-
ject of far more thorough investigation. Again, however,
there is little characterization ofworkplace atmospheres
or dose-response relationships. Between 1929 and 1945,
the Japanese Army operated a chemical warfare agent
manufacturing facility on Okuno-jima, an island of the
Inland Sea(58-63).Atpeakcapacity,thisfacilityproduced
Lewisite (50 tons/month), mustard (450 tons/month),
hydrocyanic acid (50 tons/month), diphenylcyanarsine
(sneezing gas: 50 tons/month), chloroacetophenone (tear
gas; 25 tons/month), and phosgene (unreported tons/
month). Duringthe period ofmaximum production (1937-
1942), approximately 1000 individuals were employed
throughoutthefacility. Interview dataindicate that, given
the minimal level of industrial hygiene practice in use at
the time, multiple-agent exposures were common and
agent-specific exposure occurred rarely (10,58). In the
mustard production areas, atmospheric concentrations of
mustard(estimatedat50-70mg/m3)(10)weresufficientto
produce most symptoms of acute mustard toxicity in
workers (Table 2). Mustard production workers experi-
enced numerous skin lesions (57 cases out of109 workers
engagedonlyintheproductionofmustard),theseverityof
which could be positively correlated with the years of
employment associated with mustard manufacture [mean
of 9 years (10)]. German workers exposed to sulfur and
nitrogen mustard during the dismantling of a chemical
warfare agent factory have experienced subsequent
(latentperiod,ifany,unspecified) skintumorsandnecrotic
skinulcerations thatspread andwere resistanttotherapy
(64). A high proportion of the Japanese factory workers
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also had a productive cough, irregular fevers, long-
standingchronic bronchitis, emphysematous changes, and
pleural adhesions (58,65). Astudyof156 death certificates
from former workers in the Japanese weapons factory
notedthat54%diedofrespiratorydiseases(58).Wadaand
his colleagues did not report an analysis oftobacco smok-
ing history.
It seems clear from these studies that high-level ex-
posurestomustard agent canproducepermanentrespira-
tory damage, which can take the form of a chronic
bronchitis and which can also predispose affected indi-
viduals to other respiratory infections (e.g., pneumonia,
tuberculosis). Itmust alsobe noted, however, that doses of
agent capable of producing these respiratory effects are
not well defined. An estimate of atmospheric mustard
concentration in areas of falling gas shells during World
War I is 19-33 mg/m3 (66). In the case of Japanese
workers, wartime worker safety provisions were minimal
at best, and acute toxic effects from exposure to mustard
and other chemical warfare agents were frequently
reported (59). Some workers died as a result ofacute gas
poisoning during plant operation. Another factor to be
consideredisthatoccupationallyexposedindividuals expe-
rienced daily doses to mustard as well as other warfare
agents over a period of years.
Appropriate enforcement of industrial hygiene prac-
tices can make a significant difference in the frequency
and severity of delayed respiratory effects seen among
chemical warfare agent factory workers. Manning et al.
(67) retrospectively studied a group ofworkers (N = 428)
from a British facility that manufactured mustard agent
during World War II. The only significantly increased
cause of respiratory mortality compared to controls was
that resulting from pneumonia. The observed to expected
ratio from pneumonia was 2.0 (p < 0.05) for the group of
workers studied. This elevated pneumonia incidence, how-
ever, was of borderline statistical significance, and the
significance disappeared if untraced members of the
cohort were assumed to have survived throughout the
study period. Chronic bronchitis was not found to be
significantly elevated among observed British workers.
The authors attribute the mortality differences between
the Japanese and British workers to differences in the
degree and quality of industrial hygiene measures prac-
ticed at the two weapons factories.
Application ofthefindings ofthese studies tothe Chem-
ical Stockpile DisposalProgramindicatesthatrespiratory
injurywith delayed effects could occur onlyin the event of
a major mustard release generating atmospheric con-
centrations comparable to battlefield or war gas factory
levels. AtAberdeen Proving Ground (APG) (Fig1.), where
sulfur mustard in ton containers is the onlyunitarymuni-
tion, the probability of such an occurrence during on-site
incineration disposal is less than 1 x 10-5 for the entire
period ofAPG stockpile disposal (3).
Epidemiological evidence suggests that exposures asso-
ciated with development of signiflcant respiratory effects
were either occupational exposures oflong duration to (at
least) irritating levels ofmustard, or exposures of unpro-
tected soldiers in battlefield situations. The maximum
atmospheric concentrations of mustard agent permitted
during normal incinerator plant operation (workplace
time-weighted average [TWA] of 3 x 10-3 mg/m3; gen-
eralpopulation levelTWAof1 x 10-4mg/m3; seeTable 5)
are between 103 and 105 times lower than those levels
associated with acute or delayed respiratory and skin
damage.
Carcinogenesis. The carcinogenicity ofsulfurmustard
in mammalian systems has been previously summarized
(63) and will not be detailed here. Briefly, the record of
human cancer induction is based on retrospective studies
ofpopulations exposed to acutely toxic concentrations on
the battlefield (World War I and II) or in weapons plants
operatingunderwartime conditions ofinadequateventila-
tion and industrial hygiene practices during the years
immediately before and during World War II (56-
59,62,65,68-71). StudyofOkuno-jimaworkerdeathcertifi-
catesthrough1962revealedahighincidenceofrespiratory
tract cancer (14%) and digestive tract cancer (9.6%) (58).
The remaining deaths were largely caused (39.7%) by
respiratory disease (tuberculosis or other pulmonary
infections) thought to be secondary to epithelial damage
induced byvesicant gas inhalation.
Later follow-up divided the worker population into ex-
posuregroupsbasedonjobtitle(60).Examinationofdeath
certificates and autopsy reports through 1979 found that
"Those ... who were engaged in manufacture of yperite
[mustard] and Lewisite gases had ahigh mortality due to
diseases of the respiratory tract, particularly malignant
tumors" (60). Smoking had been previously ruled out as a
factor. Retired workers were also observed to exhibit
impaired immunity (61).
Estimates ofpossible exposureconcentrations infactor-
iesandonthebattlefield rangefrom50to 70mg/M3. Itcan
be expected thatmustard-exposed survivors ofthe recent
Iran-Iraq conflict (1980-1988) will be subjects of addi-
tional studies within the next decades.
In 1975, the International Agency for Research on
Cancer (IARC) concluded that available data were suffi-
cienttosupportclassificationofmustardagentasa"group
I", carcinogen (68). This category includes compounds for
which a causal relationship between exposure and subse-
quent human cancerinduction canbe adequately substan-
tiated (72,73). Other respiratory carcinogens in IARC's
group I include arsenic, asbestos, and vinyl chloride.
The conditions ofexposure inherent to available human
retrospective studies do not permit an estimate of dose
response for sulfur mustard carcinogenicity. Animal car-
cinogenesis studies can provide more carefully defined
exposure parameters than available epidemiological stud-
ies; nevertheless, the problem of species extrapolation
Table 5. Maximum vesicant agent control limits recommended by
the Surgeon General's working group.a
Workplace General population
Agent (8 hr), mg/m3 (72-hr TWA), mg/m3
H/HD/HT 3 x 10-3 1 X 10-4
Lewisite 3 x 10-3 3 x 10-3
TWA, time-weighted average.
aValues recommended by Surgeon General's working group after
review ofpertinent data. See Carnes and Watson (5) for details.
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Table 6. Delayed/latent effects observed for the vesicant agents H/HD, HT, Lewisite, and T.
Exposure regimen
(duration) H/HD response (dose) Lewisite response T response References
Carcinogenicity
Mouse, inhalation
(15-min exposure)
Mouse, SC injection
(6 weeks)
Mouse, IV
(6 days)
Rat, inhalation
(.3-month exposure)
Human, inhalation and
skin deposition
Mouse, skin
(278 days)
Mouse, skin
Pulmonary tumors
(- 1590mg/a)a
Fibrosarcomas at injection
site( 6mg/kgbody
weight)
Pulmonary tumors
(-3-4mg/kgbody
weight)
Skin tumors
(0.1 mg/m3)b
Respiratory tract tumors,
skin cancers
(unknown)c
Negative
(2 mg total)
Negative
(dose unknown)
Heston and Levillain (79)
Heston (74)
Heston (74)
McNamara et al. (19)
Inada et al. (10); IARC (68)
Fell and Allsopp (31)
Bereblum and Shubik (76)
Mutagenicity
S. typhiimurium,
Ames test
Neurospora crassa
(30-min exposure)
Saccharamyces
cerevisiae
Drosophila
melanogaster,
parenteral injection
D. melanogaster, vapor
(5-min exposure)
D. melanogaster, vapor
(6-30 min)
D. melanogaster, vapor
(15-min exposure)
D. nrekanogaster, vapor
(15-min exposure)
D. mnelanogaster,
parenteral injection
D. melanogaster, vapor
(15-min exposure)
Mouse, ascites cells, IP
injection
(1 hr)'
Mouse, L cells
(10 min-24 hr)
Mouse leukocytes, SC
(injection)h'
Mouse leukocytes'
Mouse leukocytes'
Hamster fibroblasts
(20 min)
Human cells, HeLa'
Viciafaba (broad bean,
root meristem)
CHO cells, HGPRT
mutation assay
(1 hr)
Chromosome
aberrations,
CHO cells
(1 hr)
Positived
(1-50 ,ug/plate)
Specific locus mutation
(200 pmole/L)
DNA damage
(500 ,mole/L)
Specific locus mutation
(45 pmole/fly)
Negative
Cytogenetic damage
visible mutations,
deletions, inversions
(dose unknown)f
Sex chromosome loss and
nondisjunction
(dose unknown)f
Sex chromosome loss
and nondisjunction
(75 pmole/fly)
Heritable translocation
(dose unknown)f
DNA damage
(5 mg/kg bodyweight)
DNA damage
(1 mg/L)
Somatic cell mutation
(100 mg/kg body
weight)
Somatic cell mutation
(1 ,ug/L)
Chromosomal aberrations
(20 ,g/L)
Chromosomal aberrations
(8 ,ug/L)
DNA damage
(2 mg/L)
Sporadically positive
(0.15-0.45 mg/L)
Positive
(80-159 ,ug/L)
Negativee
(0.001-5 pRg/plate
Stewart et al. (80,81)
Dickey et al. (82)
Kircher and Brendel (83)
Fahmy and Fahmy (84)
Production of sex-linked
lethal mutations
Auerbach and Robson (85)
Auberbach and Robson (85)
Auerbach and Robson (85)
Auerbach and Robson (85)
Fahmy and Fahmy (86)
Auerbach and Robson (85)
Brookes and Lawley (87)
Reid and Walker (88)
Capizzi et al. (89)
Capizzi-et al. (89)
Capizzi et al. (89)
Savage and Breckon (90)
Ball and Roberts (91)
Negative
Negative
(24-414 ug/L)
Positive
(24-414 ,ug/L)
Loveless (92)
Jostes et al. (93,94)
Jostes et al. (93,94)
continued
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Table 6. Continued.
Exposure regimen
(duration) H/HD response (dose) Lewisite response Tresponse References
In 2itro sister Positive Negative Jostes et al. (93,94)
chromatid exchange (10-40 itg/L) (40-207 1ig/L)
assay, CHO cells
(1 hr)
D. inelanioga.ster vapor Dominant lethal mutations Auerbach and Robson (85)
(15-min exposure) (dose unknown)"
Rat, inhalation Dominant lethal mutation' Rozimarek et al. (95)
(.2weeks) Positive (male)
(0.1 mg/m,)k
Rat,intragastr ic' Dominant lethal mutations Sasser et al. (96)
Positive (male)
(0.50 mg/kg)"'
Negative (female) Sasser et al. (96)
Teratogenicity
Rat, intragastric" Negative" Negative' Hackett et al. (924,112)
Rabbit, intragastric" Negative" Negative" Hackett et al. (97,11,2)
Rat, inhalation Negative McNamara et al. (19)
(1-52 weeks)
Reproductive effects
Rat, inhalation Negative McNamara et al. (19)
(0.1 mg/m')
Rat, two-generation Negative Negative Sasser et al. (98,99)
reproduction,
intiragastiric"'
Subehronic effects
Rat, subchronic toxicity, Decreased body weight; Forestomach Sasser et al. (100,101)
intragastric forestomach epithelial lesions;s changes
hyperplasial' in serum
chemistry and
hematology
'Dose is estimated assuming complete volatilization of HD.
'Exposureto0.1mg/im ofHDwasfor 6.5hr/day, 5 days/week; fortheremainder ofeach24-hr day, animals wereexposedto0.0025mg/m'ofHDvapor.
'Exposures were either in war situations or toworkers in a mustard gas manufacturing plant duringwartime production. The duration ofexposure
for these workers was years.
'Without metabolic activation.
'Tested with and without metabolic activation.
'Difficult to estimate dose rieceived. A1:10 mixture ofmustard gas in cyclohexane was sprayed by anatomizer at 10-sec intervals in an air stream that
flowed at 2 L/min. This air stream flowed through the exposure chamber.
'Host-mediated assay.
hHost-mediated assay. Murine leukemia L5178Y cells were grown as ascites in mice.
'Duration ofexposure was not given.
'Male rats were exposed 6 hr/day, 5 days per week to 0.1 mg/m'of HD by inhalation for 1-52 weeks. They were mated to unexposed females and
(lominant lethality determined.
kEstimated total dose was 630 ,ug/kg body weight.
RHD tested at doses of 0.08, 0.20, and 0.50 mg/kg body weight.
"'Significant dominant lethal effects observed in offspring ofmale rats exposed to HD (most consistent effects observed at 0.50 mg/kg dose ofHD).
Significant increase in abnormal parental sperm observed in this dose group. F, effects include increased early fetal resorptions ancd preimplantation
losses in addition to decreased total live embryo implants.
"See text for dosages. Theatment times were gestational days 6-15 in rats and 6-19 in rabbits.
"No clear evidence ofteiratogenic effects by the agent; certain trends seen could be ascribed to maternal toxicity.
')HD tested at doses of0.03, 0.1, and 0.4 mg/kgbodyweight; L tested at doses of0.10, 0.25, and 0.60 mg/kg/day. Pregnant females were dosed 7 days/
week. Males ofthis mating group were sacrificed at birth ofthe pups. Females giving birth continued to rieceive the agent during lactation. Pups were
weaned at 21 days ofage, and the dams were sacrificed. Pups continued to receive agent for 13 weeks and were mated as above, repeating the dosing
schedule. Study concluded with sacrifice ofthe second-generation pups and their dams at weaning.
'lRats (6-7 weeks old) rieceived 0.003, 0.01, 0.03, 0.1, or 0.3 mg/kg body weight of HD 5 days/week for 13 weeks. In the L study, 6 to 7-week-old riats
received 0.01, 0.10, 0.50, 1.0, and 2.0 mg/kg body weight of agent 5 days/week for 13 weeks.
"Effects noted only in highest (0.3 mg/kg) dose group. All other parameters studied were not different from controls.
'See text for discussion.
requires consideration. Tuimorigenesis of sulfur mustard
in laboratory species ofmice and rats has been confirmed
via inhalation and injection exposure (19,74,75). Evidence
is summarized in Table 6. Thmors were not observed in
guinea pigs, rabbits, and dogs exposed to atmospheric
concentrations of0.001mg/m3 or 0.1 mg/m3 forperiods up
to 1year (19). Thelaboratory rat(Sprague-DawleyWistar)
was the only species observed to develop significantly
elevated tumorigenicity at 0.1 mg/M3. Exposure protocols
and animal strains tested for sulfur mustard tumori-
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genesis are detailed in Watson et al. (63).
Berenblum and Shubik (76) tested mustard in an
initiation-promotion study on mouse skin and found itwas
notactive as aninitiator. Thetestpromoterwas croton oil.
Doses ofmustard actually received by mice in this study
werenotwelldefinedbecausethemustardwasapplied asa
droplet onthe end ofaglass rod thathadbeen dipped into
a solution of0.1% mustard inparaffin oil. This experiment
is interesting, however, in that it demonstrated that a low
concentration of mustard was not an initiator when con-
trastedtovariouscomponentsofcoaltarappliedatsimilar
concentrations.
These animal data have been evaluated to derive an
estimate of carcinogenic potency associated with sulfur
mustardexposure aswell astoaddresstheissueofspecies
extrapolation (63). Comparisons of tumorigenicity in the
same and related species for sulfurmustard and the well-
characterized industrial carcinogen benzo[a]pyrene
(BaP) indicate that these two compounds are of approx-
imately equivalent carcinogenic potency in test animals.
This finding can be used to estimate the potential car-
cinogenic risk ofchronic inhalation ofair containing mus-
tard agent (potential agent incinerator emissions) or
ingestion ofcontaminatedfoodstuffs (potentialplumedep-
osition following an unplanned release). The calculated
lifetime cancer risk for chronic exposure to control limit
concentrations (Table 5) at maximal assumptions ofhypo-
thetical exposure during the period ofincinerator opera-
tion is as follows: a) for incinerator workers maximallv
exposed to the mustard 8-hr TWA of 3 x 10- mg/in,
calculated excess lifetime risk approximates 3 x 10-4; b)
for the general public maximally exposed to the mustard
72-hr TWA of1 x 10-4 mg/mi3, calculated excess lifetime
risk approximates 3 x 10-5 (5,63). Note that maximum
estimates of excess lifetime cancer risks for "fenceline
individuals" potentially exposed to engineering estimates
of sulfur mustard at 1.3 to 3.7 x 10-8 mg/m along the
boundaryoftheAberdeenProvingGroundduringplanned
mustard incinerator operation ranges between 4 x 10-9
and 1 x 10-8 (63). Federal agencies do notroutinelyregu-
late compounds for which the excess lifetime cancer risk
.10-6 (77). For comparison, the present U.S. lifetime
cancer incidence from all causes approximates
2.5 x 10-1V (78).
Concentrations ofmustard towhich thegeneralpopula-
tion would be exposed during an unplanned release might
be large enough to produce acute health effects. The
question arises as towhethersuch anexposuremightlead
to an increased risk of respiratory cancer. The most
relevant exposure experience for comparison is that of
World War I soldiers. Medical data available for these
veterans suggest there was some increased respiratory
cancer mortality (56,57,78). However, the increased risk
over that ofthe control population was not large and not
statistically significant. Battlefield doses were not known,
norwastheincidence ofsecondaryrespiratoryinfection or
the effect of their subsequent life experience (e.g., poor
nutrition during the Great Depression, occupational
exposures, etc.) Only limited information on smoking was
available in these studies. Occupational exposures that
proved to be carcinogenic are not comparable to the acute
exposures expected during a single accidental release;
doses that war gas factory workers received were to a
variety oftoxic compounds and were clearly large enough
and extended over a sufficient period of time (months to
years) to induce repeated acute effects.
Mutagenesis. Mustard agent induces mutagenesis in a
widevarietyoftestorganisms (seeTable6).Thecontentof
Table 6 is not intended to be encyclopedic; many other
studies could be cited in a summary ofknown mutagenic
activity for this agent. Mutations in Drosophila have
included dominantlethal andphenotypicmutations aswell
as recessive sex-linked; autosomal, and phenotypic lethal
mutations (102). Chromosomal aberrations following mus-
tard exposure include deletions, inversions, duplications,
and translocation. Mustard agent has also been demon-
strated to produce various kinds of chromosomal struc-
tural damage in plant and animal cells; structural
aberrations, chromosome stickiness, and chromosomal
breakagehaveallbeenobserved(102).Thereisnodoubtas
to the mutagenicity of sulfur mustard.
Evidence ofelevated sister chromatid exchanges (SCE)
(compared to controls) has been noted in lymphocytes of
fishermen inadvertently exposed to mustard (103) when
they dredged up leaking mustard shells discarded in the
NorthSeaafterWorldWarII. Thetimebetweenexposure
and first SCE analysis varied between 4 and 11 days. The
SCE count was still significantly elevated above matched
controls 3 weeks after exposure. The specific dose of
mustard that individuals received cannot be quantified,
but each person experienced acute toxicity in the form of
skin blisters, painful irritation of the eyes, and transient
blindness. This symptomologysuggests thatvictims expe-
rienced high doses ofmustard.
Acorrelationbetweenmutagenicactivityofacompound
and that compound's carcinogenic potency has been
observed in a number ofexperimental assays (104). In the
caseofmustardagent,sufficientevidencealreadyexiststo
classify it as a human carcinogen under appropriate
exposure conditions. Thefactthatitis amutagen supports
its classification as a carcinogen.
Reproductive Effects and Teratogenesis. Reproduc-
tive effects studies have focused on occupational popula-
tions exposed in chemical warfare agent factories for a
number ofreasons: these individuals were exposed to the
highest agent doses for the longest duration, and the
exigencies ofwartimeresultedinthepresence ofmale and
female workers. Thus, analysis of data was possible for
both genders.
Yamakido et al. (70) studied a group (N = 325) of
former workers from the Okuno-jima agent factory, their
spouses (N = 226), and their offspring (N = 456) for
possible genetic effects. The workers and their families
were divided into three groups: agentproductionworkers
who were exposed primarily to mustard and Lewisite and
who were thought to have received the largest exposures;
other factory workers, not engaged in agent production
and who probably received exposure to moderate agent
concentrations (comparedtothefirstandlastgroups); and
workers not directly involved with mustard or Lewisite
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(e.g., office workers, transportation, etc.) who were
thought to have received the lowest agent exposures.
In the first group, 18% were females, whereas there
were 17% and 64% females inthe second andthird groups,
respectively. Thegenderdistributionintheoffspringstud-
iedwas aboutequally divided between male and female. A
general health examination was carried out on all indi-
viduals under study, as well as biochemical analyses (i.e.,
starch gel electrophoresis ofplasma and erythrocyte pro-
teins) ofblood samples from offspring.
The general health examination of offspring did not
reveal evidence of any diseases that could be ascribed to
genetic effects or any abnormality that was present in
significantly different proportions from that exhibited in
parental groups. Blood analyses detected evidence of
genetic variants in a small number ofthe children exam-
ined. Specifically, six kinds of plasma protein variants
were detected in 11 children, while 11 variants of
erythrocyte proteins were found in 25 individuals. Exam-
ination of the parents demonstrated that the specific
genetic variation was also present in one or both parents,
so that each offspring's variant could not be uniquely
ascribed to a mutation induced in a parental germ cell by
mustard exposure. Yamakido et al. (70) concluded that no
evidence of mustard agent-induced mutations could be
detected in their study group.
Lohs (33) briefly summarizes a study of potential
reproductive effects in a population of German chemical
warfare agent factory workers (105). These male workers
were exposed to sulfur and nitrogen mustard under war-
time conditions in World War II, although no details of
possible exposure parameters, length of employment,
manufacture ofother agent, etc., were provided. Evidence
for dominant, sex-linked, lethal mutations was detected in
connection with an increase in the sex ratio among the
offspring of 134 fathers employed in agent production.
Impairment of various stages (unspecified) of sper-
matogenesis was also noted. It is difficult to know how
much importance should be attached to these observa-
tions. The confounding fact that workers were simul-
taneously exposed to unreported concentrations of
nitrogen mustard (a potent mutagen) as well as sulfur
mustard makes interpretation ofthe results uncertain.
A few animal studies have directly investigated the
potential of mustard agent to induce reproductive or
teratogenic effects. The potential reproductive-fetotoxic
activity oflow-level exposures to HD was studied in male
rats (19) exposed to atmospheres containing either 0.001
mg/mi3 or 0.1 mg/m3 mustard for varying time intervals
ranging from 1 to 52 weeks. Following termination of
agent exposure, male rats were bred to unexposed female
rats and pregnancy outcomes were monitored. The index
of dominant lethal mutagenesis in the F1 generation was
the percentage of dead fetuses. The percentage of fetal
death in the controls (12 month) and the ranges in the two
exposed groups (animals were tested at1,2,4,8,12,24, 36,
and 52weeks) were as follows: 4.12% (control); 1.18-8.60%
(low mustard exposure); and 1.72-21.05% (high mustard
exposure). Thehighestpercentage offetaldeaths (21.05%)
intheoffspringofthehigh-exposuregroupoccurredinthe
litters bred from males that underwent 12 weeks of
exposure. Other elevated values were seen in the highest
exposure group after 4 weeks (10.1%), 24 weeks (10.3%),
and 52 weeks (12.5%). No statistical evaluation of these
differences are published in the report. McNamara et al.
(19) concluded thattherewas no evidence formutagenesis
and that no differences between control and experimental
groups were observed. Perhaps McNamara's conclusions
were based on statistical analyses thatwere not explicitly
stated; the current analysis considers that the elevated
fetal mortality in the high-exposure group suggests a
possible connection between agent exposure in the male
and fetal death.
Conclusions differing fromthat ofMcNamara et al. (19)
werereachedbyRozimareketal. (95)intheirevaluationof
thesamedataset. Rozimarekandhiscolleaguesconcluded
that significant dominant lethal mutagenesis was ob-
served in the high-exposure (0.1mg/m3) group. The domi-
nant lethal mutation rate attained a maximum of 9.4%
after 12 weeks of exposure and did not alter following
successively greaterexposureperiods. Thereasonforthis
difference in interpretation between authors is unclear.
Experimental results seem to atleast suggest some effect
of HD exposure on mammalian male fertility.
Further studies by McNamara et al. (95) investigated
the effect oflow-level HD exposures on fetal toxicitywhen
pregnant female rats were directly exposed to HD. Ani-
malswere exposed to the same two HD airconcentrations
as in the male study (i.e., 0.001 and 0.1 mg/m3) during the
first, second, or third weeks of gestation, or during the
entire pregnancy. No change in fetal mortality was
observedwhentheexposedgroupwascomparedtocontrol
groups.
Teratology studies in rats and rabbits were conducted
more recently (97). Pregnant rats were exposed to mus-
tard doses of 0.2, 0.4, 0.8, 1.6, 2.0, and 2.5 mg/kg body
weightbygastricintubation fromdays 6 to 15 ofgestation
and sacrificed on day 20 in a range-finding study. On the
basis ofthis preliminary study, HD doses of 0.5, 1.0, and
2.0mg/kgwereusedintheteratologystudy, overthe same
gestational period, and with the same sacrifice schedule.
Therewasasignificant(p .0.05) decrease inbodyweight
(compared to controls) ofpregnant rats in the 1.0 and 2.0
mg/kg dose groupby 9 days ofgestation. Similarfindings
werenoted at12 daysofgestationinthe 0.5mg/kggroups.
Thus, some evidence ofmaternal toxicity was seen at all
dose levels. An increase in litter resorptions was noted in
the treatment groups, but this effect was not statistically
significant. There was a significant decrease in fetal body
weights in the 1.0 and 2.0 mg/kg dose groups. No signifi-
cant level of increase in major fetal malformations was
seeninanydosegroup,butthenumberofminoranomalies
(e.g., misaligned sternebrae [embryonic segments which
eventually develop into the sternum]) was signiflcantly
increased in the highest dose group. The authors con-
cluded thatthefetalfindings observed couldbe attributed
to the evident maternal toxicity produced by HD.
Pregnant rabbits were also used in the same studies to
detect potential HD teratogenicity (97). In the range-
finding study, rabbits received 0.5, 1.0, 2.0, or 2.5 mg/kg
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body weight of HD for days 6-19 of gestation and were
sacrificed on day 30 ofgestation. Doses of 1 and 2 mg/kg
produced maternal mortality, so the teratology studywas
limitedtodosesof0.4,0.6, and0.8mg/kgofHD.Therewas
no evidence ofsignificanteffects onintrauterine growth or
fetal growth and development at these doses. A higher
percentage ofresorptions in the two highest dose groups
was noted. The major finding was evidence of maternal
toxicity, as evidenced by a significantly depressed weight
gain in the 0.8 mg/kg dose group from 11 to 20 days of
gestation. The authors concluded that both rabbit and rat
studies indicated that HD was not teratogenic, since the
effects observedwere atdoseswhichproduced overtsigns
ofmaternal toxicity.
Results of further studies of possible reproductive
effects carried out at the Pacific Northwest Laboratory
(Richland,Washington) are summarized inTable 6(96). In
the dominant lethal mutation study, male or female rats
received HD by gavage for 5 days/week, for 10 weeks.
Exposed females were then mated to either unexposed or
exposed males during a 3-week, post-exposure mating
period. To evaluate male dominant lethal effects, exposed
male rats were mated to unexposed females during a 10-
week mating period following exposure. No evidence of a
significantfemaledominantlethaleffectwasobserved,but
asignificantmaledominantlethaleffectwasnoted,partic-
ularly at the highest dose (0.50 mg/kgbodyweight) used.
Furthermore, sperm abnormalities (abnormal sperm
heads) were observed to be significantly (p < 0.05) ele-
vatedinthis dosegroup. Thus, HDhasbeendemonstrated
to produce reproductive effects in male rats under the
particular set ofexposure conditions used in this study.
Sasser et al. (98) carried out a two-generation study in
rats gavaged with 0.03, 0.1, or 0.4 mg/kg/day, according to
the dosing protocol detailed in Table 6. Males who had
mated with females were sacrificed at the birth of their
pups. Dams who had given birth were sacrificed when the
pups wereweaned. Male and female F1 pups received HD
until they were mated, the females became pregnant and
gavebirth.Atthispoint, F1 males(fathers)weresacrificed
and F1 dams continued on the dosage schedule until
weaning, at which point the study was terminated. Thus,
two generations ofrats received chronic exposure to HD,
with each generation going through a mating cycle. Simi-
larly, two generations of pups were born to parents who
had received HD. All animals in this studywere examined
for evidence of adverse effects on reproductive perfor-
mance, fertility, or reproductive organ weights. In addi-
tion, gross and microscopic examinations ofreproductive
organs were carried out on all groups. There was no
evidence ofadverse reproductive effects at the HD doses
tested. However, there was a significant inhibition of
growth (i.e., reduced bodyweight gain) in the rats ofboth
sexes (the F1 generation) born to parents who had
received the highest dose (0.4 mg/kg/day) of HD. The
authors conclude that the HD exposures did not affect
reproductive performance or fertility.
In addition to the rat studies, dominant lethal effects
have also been observed in fruit flies (85) (Table 6). The
exposure necessary to produce this effect is not clearly
stated bytheinvestigators, and the extrapolation between
insects and mammalian species is not straightforward.
In summary, evidence from both human and animal
studies regarding the reproductive toxicity ofmustard is
generally negative, except for the evidence of dominant
lethal mutations in exposed male rats (96). In some cases,
effects are noted, but other similar studies are negative.
The evidence from the German chemical warfare agent
factoryworkerpopulations suggests an adverseeffect,but
it is not clear that this is due solely to sulfur mustard
exposure. We do not consider this positive result to be of
more importance than the negative findings in the more
fully characterized Japanese worker population. In any
case, the human occupational exposures in the few avail-
able studies were almost certainly to high levels ofagents
for long durations; in addition, workers were essentially
without protective equipment. Unplanned release sce-
nariosthatmightoccurduringchemicalstockpiledisposal
are not comparable (37). As a result, reproductive effects
from mustard exposure are unlikely for occupational or
general populations during the sulfur mustard disposal
process.
Other Effects. A variety of other delayed effects from
mustard exposure, some rather ill defined, are also pre-
sented in the literature (106). Among workers in mustard
agent factories before and during World War II, the
following delayed effects were observed: periodontitis
leading to tooth decay; osteoporosis; premature aging;
elevated pH of stomach fluid; liver injury (rare); and
unspecified injuries of the central nervous system. The
types of exposures (multiple agents? concentration? pro-
tective measures?) and durations that were associated
with these effects are not stated and have not been docu-
mented elsewhere (58,67).
Healed skin lesions may exhibit evidence ofpermanent
damage. There is often some alteration ofpigmentation at
the site of damage and the affected areas are often
unusually sensitive to subsequent mechanical injury. A
mild contusion or abrasion afterwhat appears to be com-
plete healing may produce one or more blisters (36).
McNamara et al. (19) studied a number ofphysiological
parameters in laboratory animals (rabbits, guinea pigs,
and dogs) during their chronic exposure ex eriments at
airconcentrations of0.1mgi3 or0.001mg/mi ofHDfor5
days/week, for periods of 1-52 weeks. Experimental ani-
mals were closely monitored for any toxic signs resulting
from exposure. No overt toxic signs were detected in any
experimental animals exposed to 0.001 mg/m3 forup to 52
weeks. Corneal opacity, chronic keratitis of the eye, and
excess vascularization, pigmentation, and granulation of
theeyewerenotedindogsexposedformorethan16weeks
to 0.1 mg/m3; no other animal species tested exhibited
overttoxic signs on exposure to this concentration. Hema-
tologic parameters such as red blood cell count, hema-
tocrit, white blood cell count, and serum enzymes in
exposed rabbits and dogs were not significantly different
from those of control animals. There was a tendency
towardelevatedconcentrations ofthebloodenzyme serum
glutamic-oxalic transaminase (SGOT) in dogs after 12-28
weeks of exposure to 0.1 mg/m3 of HD, although no
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statisticalanalysis ofthistrendwasreported.Thisfinding
could be an indicator of liver and/or heart tissue injury.
McNamara et al. (19) also observed that the serum
albumin/globulin ratios of dogs exposed to either con-
centration of HD for 52 weeks was unchanged when
comparedto controlvalues. None ofthe speciesexposed to
eitherconcentration ofHD displayed anyevidence ofskin,
eye, or respiratory tract sensitization. An antigen chal-
lenge in a rabbit exposed to 0.1 mg/m3 of HD for 1 year
produced an essentially normal response (19).
A study ofsubehronic HD toxicity in rats was recently
reportedby Sasser etal. (100) (Table 6). Inthis study, rats
received a 13-week exposure to various HD doses by
gavage and were monitored for various parameters/
toxicological signs including body weight, evidence of
moribundity, hematological parameters including selected
serum enzymes (serum glutamic-pyruvic transaminase
[SGPT] andSGOT,which are consideredindicators ofliver
function), and an opthalmologic examination at the begin-
ning and end of the study. At sacrifice, a gross necropsy
andmicroscopic exam ofselectedtissueswasmade. There
was no evidence of adverse toxic effects other than the
conditions noted in Table 6. Given the known cellular
toxicity of HD, it is perhaps not surprising that fore-
stomach hyperplasia was observed, as this would be the
tissue to receive immediate contactwith HD duringintra-
gastric dosing.
Agents HT/T
No data specific to delayed toxicity of agent HT were
identified duringpreparationofthisreview. Because HTis
a mixture ofabout 60% distilled mustard (HD) and up to
40% agent T (described in Table 1), it is expected that
delayed effects of HT would encompass those of both
mustard formulations H/RD as well as agent T.
Agent T is highlymutagenic (107), with a demonstrated
ability to produce sex-linked lethal mutations in Droso-
phila melanogaster on an order comparable to that of
mustard agent and X-rays. A standard ClB test mated
untreated adultfemales with adultmales exposed to 5 min
ofvolatilized, neat, agent T (85). The 8.5% lethal mutation
rate observed in the resulting F1 progeny indicates a
significant induction oflethal mutations on the X-chromo-
some ofthe spermatozoa (normal percentage ofF1 lethals
in D. melanogaster ranges between 0.1 and 0.4%) (107).
Further experiments by Auerbach and Robson (52) sug-
gest that agent T may have the capacity to induce chro-
mosomal rearrangements in D. melanogaster. However,
the corroborative data for this effect are considered sug-
gestive ratherthanconclusive.Whileresults from asingle
insect species cannot be considered an absolute indication
of mutagenic activity in human systems, the data repre-
sent reason for caution.
Agent L (Lewisite)
The literature on potential delayed or latent effects of
Lewisite exposure is somewhat limited, at least in com-
parison to HD. There is some relevant experience regard-
ing human exposures to Lewisite in combination with
other agents (i.e., workers in chemical warfare agent
factories). Probably the most complete data has emerged
from recent work sponsored by the U.S. Army Medical
Research and Development Command in Fort Detrick,
Maryland (99,101). The following discussion relies heavily
on these results, in addition to a few studies ofWorld War
II vintage.
The ability of Lewisite to produce sex-linked lethal
mutations and chromosomal rearrangements among the
F1 generation of exposed adult D. melanogaster was
testedinthePharmacologyDepartmentofthe University
ofEdinburgh duringWorldWarIIandreportedprimarily
in the late 1940s (52,108). All results were negative. The
mutagenicity ofLewisite has also been investigated in the
Ames assay (bacterial mutation) and in mammalian cells
(81,94) (Table 6). Neitherthebacterial normammalian cell
assay provide convincing evidence ofmutagenicity. Acon-
founding factor is the powerful cytotoxicity of Lewisite.
The higher doses of Lewisite (Table 6) resulted in exten-
sivecellkilling, andmutants couldonlybe detected among
thesurvivingfraction. Besidesmutation ataspecificlocus,
cytogenicassayswereusedinthestudyofLewisiteeffects
on mammalian cells. Although evidence for aweakly posi-
tiveSCE responsetoLewisitewasobserved, theSCE rate
was not significantly different from control values (94).
Chromosomal aberrations were significantly increased in
Chinese hamster ovary cells treated with Lewisite. This
result indicates Lewisite can produce chromosome
damage under appropriate experimental conditions (94).
How this might apply to Lewisite exposures among
humans is unclear.
The few cases of long-term follow-up indicate that car-
cinogenicity maybe an effect ofacute Lewisite exposures.
Aformerinfantryman inthe German OccupationArmyof
France during World War II received an accidental
exposure to liquid Lewisite on the skin ofhis lower right
legin 1940 (109). Immediatelyupon exposure, intensepain
ensued and a blistered lesion formed; the wound never
healed. In 1948, the ulcerated lesion was diagnosed as
malignant, surgically removed, and later treated with
X-rays.By1978,theulceratedareainvolvedtheinnerthird
ofthe victim's lower leg and was histologically diagnosed
as Bowen's disease, an intraepidermal squamous cell car-
cinoma. Atthe time oflastreport (109), thepatientwas 77
years old, in otherwise good health, and receiving pallia-
tive treatment38years afterasingle exposure. Nometas-
tasis was noted.
Other human evidence is less direct. The Okuno-jima
chemical warfare agent factory operated by the Japanese
Army from 1929 through 1945 produced Lewisite, as well
as sulfur mustard and several other irritant compounds
forwartime use againstpersonnel. Operations details are
providedinthe sulfurmustardtextaboveandinWatsonet
al. (63), Tanaka (62), Wada et al. (58,59), and Nishimoto et
al. (60,61). Several cases of Bowen's disease were also
noted among former workers of the Okuno-jima facility
(10). It is unclear whether these cases were induced by
single-agent exposure or by combined exposure from the
arsenic in Lewisite and diphenylcyanarsine plus mustard
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agent. As previously discussed, protective clothing, ven-
tilation, monitoring, and sanitation were poor or nonexis-
tent, and many workers suffered severe exposures. Be-
cause each worker was exposed to both agents, it is not
possible to completely distinguish Lewisite from mustard
agentasacarcinogeninthesestudies. Furthermore,there
are no quantitative estimates of dose or exposure rates,
although they must have been high under the wartime
conditions described. However, there are sufficient datato
suggest that Lewisite may be a carcinogen at elevated,
sublethal exposures that cause blistering and pain.
Teratogenic properties and reproductive toxicity of
high-level Lewisite exposure are suspected but have not
been substantiated. The active arsenical groupin Lewisite
is thought to react with proteins and could thus affect
developing offspring (110,111). Several experiments
designed to examine aspects of reproduction have been
recently completed by the U.S. Army Biomedical Engi-
neering Research and Development Laboratory
(USABRDL) (99,112). Examination of maternal and fetal
effects was accomplished by exposing pregnant rats and
rabbits to Lewisite by gastric intubation at a daily dose
range of0-1.5 mg/kgforrats and 0-0.6 mg/kgfor rabbits.
In the rat study, no evidence of teratology or maternal
toxicitywasobtained. Rabbitswerefoundtobemuchmore
sensitive to the toxic effects of Lewisite. A very signifi-
cantly elevated maternal mortality was observed in the
Lewisite-treated groups ofrabbits. Furthermore, mater-
nalweight gain was significantly depressed atthe 0.6mg/
kg dose level. Because of the toxicity of Lewisite, the
number ofsurviving litters was smaller than anticipated,
so statistical comparisons among treatment and control
groupswere less reliable than hadbeen hoped for. Placen-
tal weights and fetal body weights showed a trend (not
statistically significant) toward lower values in the
Lewisite-treated rabbits. The incidence of major malfor-
mations was not elevated in any of the groups of rabbits
exposed tothevarious Lewisite doses. However, therewas
asignificant(p . 0.05) increase in incidence of, otherwise
normal, stunted fetuses (defined as having body weight
.2 standard deviations ofthemeanbodyweight) in dams
treated with the 0.6 mg/kg Lewisite dose. In this latter
group, the incidence of fetuses with supernumerary ribs
and reduced pelvis ossification was also significantly ele-
vated. The conclusion from these studies was that the
effects observed in the fetuses were likely to be due to
maternal toxicity.
Sasseretal.(99)havestudiedthereproductiveeffectsof
Lewisite exposure in atwo-generation reproductive study
in rats (Table 6). Therewere noadverse effects ofLewisite
exposure on reproductive performance, fertility, or
reproductive organweights observed in this study. Minor
(but statistically significant) decrease in growth among
females (both generations) was noted. Histopathologic
study ofvarious tissues did notidentify atarget organ for
the site of Lewisite action. The authors again note the
strong toxicity of Lewisite which deterred them from
being able to use higher doses in this study.
The effect of Lewisite on rats was also studied in a 90-
day subchronic toxicity study (101) (Table 6). Avariety of
toxicitymeasures were monitored, includingbodyweight,
ophthalmology, hematology, various serum proteins and
enzymes, as well as histopathological evaluations of col-
lected tissues. No effects on body weight were observed.
Significant (p < 0.05) decreases in total serum protein,
serum creatinine, and the serum enzymes SGOT and
SGPT were observed in male animals in the highest dose
(2.0 mg/kg) group at 13 weeks. The SGOT effect was
observed in all the other Lewisite dose groups in the male
animals. In females, there were significant increases in
lymphocytes andplatelet countsinthehighestdosegroup.
The lymphocyte increase was observed at 6 weeks (the
only time other than 13 weeks when hematology was
performed) but not at 13 weeks. The platelet count was
elevated at 13 weeks. The investigators were not able to
interpret the significance, ifany, ofthese various changes
in hematologic and enzymatic parameters.
Ofpossiblymore importance was the consistentfinding
of forestomach lesions in both rat genders given the
highest Lewisite dose (2 mg/kg). This finding was
observed in 80% of the males and 40% of the females at
this dose group, and in 10% of the males in the 1 mg/kg
dose group. These lesions were described as involving
necrosis of the stratified squamous epithelium accom-
panied by infiltration of neutrophils and macrophages,
hemorrhage, edema, and fibroblast proliferation. In a few
instances, the epithelium adjacent to ulcerated areas was
hyperplastic. In addition to the forestomach lesions, acute
inflammation ofthe glandular stomach was seen in 10% of
the males and 30% ofthe females in the high dose group.
Thislesionwas described asverymild. Thelesions seenin
the forestomach and glandular stomach probably are con-
sistent with the irritant action of Lewisite when admin-
istered by gavage. The investigators found no evidence
that the forestomach lesions were precancerous. They
were also careful to point out that this was a subehronic
toxicitystudy, andthelengthoftreatmentwasinsufficient
to determine carcinogenicity.
Conclusions
Available data characterizing dose response tovesicant
(blister) agent exposure are summarized from unclassi-
fied, internalArmy reports as well as the open literature.
Acute and delayed toxicity ofvarious sulfur mustard for-
mulations (H, HD, and HT) and Lewisite are now docu-
mented in a readily accessible form useful for emergency
planning.
Historical military data from World War I and the
recentIran-Iraqconflictindicatethatacutelethalityrates
following battlefield exposures to sulfur mustard agents
(estimated 1500 mg-min/m3) range between 1 and 3%.
Mustard "gas" was responsible for 0.5% of World War I
battlefielddeaths(i.e.,600ofthe126,000Americandeaths).
Vesicants are cellular poisons in target tissues. Sulfur
mustard is an alkylating agent; individual cells are
destroyed by the chemical reaction ofmustard with cellu-
lar proteins, enzymes, and nucleic acids. Lewisite, an
organic arsenical, alsoproduces cell death, butbyaltering
critical cellular enzyme systems.
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Following exposure to any formulation of sulfur mus-
tard agent, humans usually undergo a latency period of
several hours before signs of toxicity begin to appear.
These signs include eye inflammation (occurs at lower
doses than any other effect and is therefore the most
sensitiveindicatorofmustardagentexposure), skinirrita-
tion (rash or blisters), and irritation of the respiratory
tract. Moist tissues are particularly vulnerable. Recovery
from these toxic effects can take days orweeks. The more
serious acute effects are certainly disabling, although
usuallynotpermanently so; specialcareandresources are
required topreventsubsequentinfectionoftheskin,respi-
ratory tract, and eyes. The difference between a lethal
percutaneous dose (estimated LCt50 of10,000mg-min/m3)
and a lethal inhalation dose (estimated LCt50 of1500 mg-
minim3) is approximately 10-fold; respiratory protection
eveninthe absence ofanyotherprotective clothingisthus
critical in an environment where mustard exposure is
likely.
Dose response to H and HD is temperature dependent,
in part due to the relatively high freezing point of sulfur
mustard (8°-14°C). Percutaneous response at > 14°C
ambient is a function of skin temperature and moisture,
which are largely controlled by ambient temperature.
Between 210 and 27°C ambient, 2000 mg-minim3 is neces-
saryto generate an incapacitating percutaneous dose to a
masked individual; at32°C ambient, only1000mg-min/m3
is required for the same response.
Mustard agent exposure can also produce delayed or
latenteffects.Apparenthealingofeyedamage afteracute,
high-level exposure can be followed by delayed keratopa-
thy over the course ofyears, although this effect is infre-
quent. Following sufficiently severe exposure, respiratory
tract damage can result in chronic bronchitis and
emphysema. Epidemiological evidence and results of ani-
mal studies both indicate that sulfur mustard agents can
induce cancer. World War I veterans and workers in
armamentfactorieswhowere exposed tointenselyirritat-
inglevelsofthisagentunderwartimeconditions developed
respiratory tract and epithelial malignancies. Because of
its highly reactive chemical nature, mustard agent can
reactwith DNAto produce mutations in microbial, insect,
and mammalian cell culture lines, insect colonies, and the
offspring of male rats undergoing intragastric exposure
to HD at 0.5 mg/kg (dominant lethal mutations observed
as early fetal resorptions, etc., in the F1 generation were
associated with abnormalparental sperm). Evidencefrom
epidemiological studies ofarmament factoryworkers has
yet to reliably demonstrate that exposure to sulfur mus-
tard agents produces reproductive effects in humans.
Recent, two-generation intragastric exposure ofmale and
female rats to HD resulted in no observed effects on
reproductiveperformance, fertility, orreproductive organ
weights ofmales and females.
Toxicity of agents HT and Lewisite are not as well
characterized as sulfur mustard, but it is clear that these
agents possess generally similar vesicant properties.
Agent HTis more stable andmore acutelylethal than HD.
It is considered carcinogenic because of the presence of
HD and mutagenic because both HD and T (bis[2(2-
chloroethylthio)ethyl]ether) react with nucleic acids.
Lewisite does not exhibit the latency period displayed by
mustard agent and is noted for causing immediate pain
upon contact with the skin and eyes (a sensitive indicator
of exposure). There are major differences between lethal
inhalation doses (estimated LCt50 of1200to 1500mg-min/
m3) and percutaneous doses (estimated LCt50 of100,000
mg-min/m3) for masked individuals exposed to agent L.
Lewisite is also known to be a systemic poison (liver and
kidneys) at sufficiently large doses. Among military per-
sonnel and armament factoryworkerswho received large
dermalexposures, agentLhasbeenassociatedwithinduc-
tion of Bowen's disease, a relatively slow-growing and
usually nonfatal intraepidermal squamous cell carcinoma.
Recent mammalian assays, which included a two-gen-
eration rat study, did not demonstrate teratogenicity or
reproductive effects atthedosestested. However,thehigh
cytotoxic potency of Lewisite may have precluded such
observations.
No acute vesicant effects are expected at the recom-
mended inhalation exposure control limits documented in
Table 5. However, because current Federal regulatory
thinking considers that carcinogenesis exhibits a linear,
nonthreshold dose response, anylevel ofexposure poses a
degree ofcalculated cancer risk.
This paperwas prepared for the U.S. Department ofthe Army, Office
of the Assistant Secretary, Installations, Logisitics, and Environment
under Interagency Agreement DOE no. 1769-1354-Al. This paper was
prepared bythe Oak Ridge National Laboratory, Oak Ridge, Tennessee,
managed byMartin Marietta Energy Systems, Inc., fortheU.S. Depart-
ment ofEnergy under contract no. DE-AC05-840R21400.
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